EFEMORAL MEDICAL, INC. (20240315857). ABSORBABLE INTRAVASCULAR STENTS HAVING A THERAPEUTIC DRUG WITHIN THE SCAFFOLD simplified abstract
Contents
ABSORBABLE INTRAVASCULAR STENTS HAVING A THERAPEUTIC DRUG WITHIN THE SCAFFOLD
Organization Name
Inventor(s)
LEWIS B. Schwartz of Lake Forest IL (US)
IVAN Tzvetanov of Mountain View CA (US)
ALEX Estrada of Menlo Park CA (US)
Michal Eugene of San Anselmo CA (US)
ABSORBABLE INTRAVASCULAR STENTS HAVING A THERAPEUTIC DRUG WITHIN THE SCAFFOLD - A simplified explanation of the abstract
This abstract first appeared for US patent application 20240315857 titled 'ABSORBABLE INTRAVASCULAR STENTS HAVING A THERAPEUTIC DRUG WITHIN THE SCAFFOLD
- Simplified Explanation:**
The patent application describes devices, systems, and methods for maintaining or enhancing blood flow through a blood vessel using a bioresorbable vascular stent. The stent element includes a scaffold and coating layer with a bioresorbable structural polymer and therapeutic drug integration. The manufacturing process involves additive manufacturing techniques.
- Key Features and Innovation:**
- Bioresorbable vascular stent for blood flow maintenance - Scaffold and coating layer with bioresorbable structural polymer - Integration of therapeutic drug within the scaffold - Additive manufacturing process for stent production
- Potential Applications:**
- Treatment of vascular diseases - Stent implantation in blood vessels - Drug delivery for targeted therapy
- Problems Solved:**
- Maintaining or enhancing blood flow through blood vessels - Providing bioresorbable stent options - Controlled drug delivery within the blood vessel
- Benefits:**
- Improved blood flow management - Reduced risk of complications from stent implantation - Targeted drug delivery for effective treatment
- Commercial Applications:**
Title: Bioresorbable Vascular Stent Technology for Enhanced Blood Flow Management This technology can be used in medical devices for vascular interventions, pharmaceutical drug delivery systems, and research in bioresorbable materials. The market implications include improved patient outcomes, reduced healthcare costs, and potential partnerships with medical device companies.
- Questions about Bioresorbable Vascular Stent Technology:**
1. How does the bioresorbable nature of the stent impact patient recovery after implantation? The bioresorbable nature of the stent allows for natural degradation over time, reducing the risk of long-term complications and potentially improving patient recovery.
2. What are the potential challenges in manufacturing bioresorbable vascular stents using additive manufacturing techniques? Additive manufacturing may require specific expertise and quality control measures to ensure the stents meet regulatory standards and performance requirements.
Original Abstract Submitted
devices, systems, and methods are provided to maintain or enhance blood flow through the blood vessel as a stent. the balloon-expandable, bioresorbable, vascular stent elements are configured to be implanted in the blood vessel are described herein. the stent element comprises a scaffold and coating layer comprising a bioresorbable structural polymer. a therapeutic drug is provided both on a scaffold coating and integrated within the structural polymer of the scaffold. the method of making the bioresorbable, vascular stent includes an additive manufacturing process described herein.
